However, AD, prodromal AD cases, and healthy controls were evaluated using CSF amyloid and tau levels known to have high specificity and sensitivity for prodromal AD and AD, improving the diagnostic certainty of these cases. The gene discussed is MAPT; the disease is Alzheimer disease.